Chrysemys picta bellii isolate RCT428 chromosome 24, Chrysemys_picta_BioNano-3.0.4, whole genome shotgun sequence.
Chrysemys picta bellii (western painted turtle)
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Archelosauria; Testudinata; Testudines; Cryptodira; Durocryptodira; Testudinoidea; Emydidae; Chrysemys.
Physical Mapping and Refinement of the Painted Turtle Genome (Chrysemys picta) Inform Amniote Genome Evolution and Challenge Turtle-Bird Chromosomal Conservation
REFSEQ INFORMATION: The reference sequence is identical to\nCM002671.2.\nOn Aug 10, 2021 this sequence version replaced NC_024234.1.\nAssembly name: Chrysemys_picta_BioNano-3.0.4\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Painted turtle genome\nsequencing consortium on 2020/08/21. The original whole-genome\nshotgun project has the accession AHGY00000000.3.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Painted turtle genome sequencing\n consortium\nAssembly Method :: Newbler v. 2.6\nAssembly Name :: Chrysemys_picta_BioNano-3.0.4\nGenome Coverage :: 19.2x\nSequencing Technology :: 454 Life Sciences\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Chrysemys picta Annotation Release\n 103\nAnnotation Version :: 103\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
small lake 1.3 miles south of Potholes Reservoir
Derived by automated computational analysis using gene prediction method: Gnomon.
COORDINATES: polyA evidence [ECO:0006239]
aldehyde dehydrogenase 4 family member A1, transcript variant X2
delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial isoform X2
aldehyde dehydrogenase 4 family member A1, transcript variant X1
delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
FA core complex associated protein 20, transcript variant X4
FA core complex associated protein 20, transcript variant X1
Fanconi anemia core complex-associated protein 20 isoform X1
Fanconi anemia core complex-associated protein 20 isoform X3
FA core complex associated protein 20, transcript variant X2
FA core complex associated protein 20, transcript variant X3
Fanconi anemia core complex-associated protein 20 isoform X2
protein kinase C zeta, transcript variant X2
protein kinase C zeta, transcript variant X1
protein kinase C zeta, transcript variant X3
protein kinase C zeta, transcript variant X6
protein kinase C zeta, transcript variant X5
protein kinase C zeta, transcript variant X7
protein kinase C zeta, transcript variant X4
gamma-aminobutyric acid type A receptor subunit delta, transcript variant X1
gamma-aminobutyric acid type A receptor subunit delta, transcript variant X2
gamma-aminobutyric acid receptor subunit delta isoform X1
gamma-aminobutyric acid receptor subunit delta isoform X2
cilia and flagella associated protein 74, transcript variant X1
cilia and flagella associated protein 74, transcript variant X4
cilia and flagella associated protein 74, transcript variant X3
cilia and flagella associated protein 74, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
cilia and flagella associated protein 74, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cilia and flagella associated protein 74, transcript variant X2
cilia and flagella associated protein 74, transcript variant X5
cilia- and flagella-associated protein 74 isoform X1
cilia- and flagella-associated protein 74 isoform X4
cilia- and flagella-associated protein 74 isoform X3
cilia- and flagella-associated protein 74 isoform X2
cilia- and flagella-associated protein 74 isoform X7
cilia- and flagella-associated protein 74 isoform X10
cilia- and flagella-associated protein 74 isoform X5
cilia and flagella associated protein 74, transcript variant X6
cilia- and flagella-associated protein 74 isoform X6
cilia and flagella associated protein 74, transcript variant X8
cilia and flagella associated protein 74, transcript variant X9
cilia- and flagella-associated protein 74 isoform X8
cilia- and flagella-associated protein 74 isoform X9
calmodulin like 6, transcript variant X2
calmodulin like 6, transcript variant X4
calmodulin like 6, transcript variant X3
calmodulin like 6, transcript variant X1
guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC101952142, transcript variant X2
uncharacterized LOC101952142, transcript variant X3
uncharacterized LOC101952142, transcript variant X1
uncharacterized protein LOC101952142 isoform X2
uncharacterized protein LOC101952142 isoform X3
uncharacterized protein LOC101952142 isoform X1
uncharacterized LOC101952142, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
solute carrier family 35 member E2A, transcript variant X5
solute carrier family 35 member E2A, transcript variant X1
solute carrier family 35 member E2A, transcript variant X2
solute carrier family 35 member E2A, transcript variant X4
solute carrier family 35 member E2A, transcript variant X3
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: cyclin-dependent kinase 11B-like
MIB E3 ubiquitin protein ligase 2, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
E3 ubiquitin-protein ligase MIB2 isoform X6
MIB E3 ubiquitin protein ligase 2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
E3 ubiquitin-protein ligase MIB2 isoform X4
MIB E3 ubiquitin protein ligase 2, transcript variant X6
MIB E3 ubiquitin protein ligase 2, transcript variant X8
MIB E3 ubiquitin protein ligase 2, transcript variant X1
MIB E3 ubiquitin protein ligase 2, transcript variant X2
MIB E3 ubiquitin protein ligase 2, transcript variant X4
MIB E3 ubiquitin protein ligase 2, transcript variant X3
MIB E3 ubiquitin protein ligase 2, transcript variant X12
MIB E3 ubiquitin protein ligase 2, transcript variant X11
MIB E3 ubiquitin protein ligase 2, transcript variant X10
E3 ubiquitin-protein ligase MIB2 isoform X3
E3 ubiquitin-protein ligase MIB2 isoform X1
E3 ubiquitin-protein ligase MIB2 isoform X9
E3 ubiquitin-protein ligase MIB2 isoform X8
E3 ubiquitin-protein ligase MIB2 isoform X7
E3 ubiquitin-protein ligase MIB2 isoform X5
MIB E3 ubiquitin protein ligase 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
E3 ubiquitin-protein ligase MIB2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Golgi integral membrane protein 4-like, transcript variant X2
Golgi integral membrane protein 4-like, transcript variant X3
Golgi integral membrane protein 4-like, transcript variant X1
Golgi integral membrane protein 4-like, transcript variant X4
Golgi integral membrane protein 4-like isoform X1
Golgi integral membrane protein 4-like isoform X3
Golgi integral membrane protein 4-like isoform X2
fibronectin type III domain containing 10
fibronectin type III domain-containing protein 10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 22% coverage of the annotated genomic feature by RNAseq alignments
SSU72 homolog, RNA polymerase II CTD phosphatase
RNA polymerase II subunit A C-terminal domain phosphatase SSU72
transmembrane protein 240, transcript variant X2
transmembrane protein 240, transcript variant X1
ATPase family AAA domain-containing protein 3-like
von Willebrand factor A domain containing 1
von Willebrand factor A domain-containing protein 1
transmembrane protein 88B, transcript variant X1
transmembrane protein 88B, transcript variant X2
ankyrin repeat domain 65, transcript variant X1
ankyrin repeat domain 65, transcript variant X2
ankyrin repeat domain-containing protein 65 isoform X1
ankyrin repeat domain-containing protein 65 isoform X2
39S ribosomal protein L20, mitochondrial
dishevelled segment polarity protein 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
dishevelled segment polarity protein 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
dishevelled segment polarity protein 1, transcript variant X1
dishevelled segment polarity protein 1, transcript variant X2
segment polarity protein dishevelled homolog DVL-1 isoform X1
segment polarity protein dishevelled homolog DVL-1 isoform X2
segment polarity protein dishevelled homolog DVL-1 isoform X4
segment polarity protein dishevelled homolog DVL-1 isoform X5
dishevelled segment polarity protein 1, transcript variant X3
segment polarity protein dishevelled homolog DVL-1 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 64% coverage of the annotated genomic feature by RNAseq alignments
lysophosphatidic acid receptor 6-like, transcript variant X3
lysophosphatidic acid receptor 6-like, transcript variant X2
lysophosphatidic acid receptor 6-like, transcript variant X4
lysophosphatidic acid receptor 6-like, transcript variant X1
pseudouridine synthase like 1, transcript variant X3
pseudouridine synthase like 1, transcript variant X2
pseudouridine synthase like 1, transcript variant X1
tRNA pseudouridine synthase-like 1 isoform X2
tRNA pseudouridine synthase-like 1 isoform X3
tRNA pseudouridine synthase-like 1 isoform X1
ArfGAP with coiled-coil, ankyrin repeat and PH domains 3
arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 3
sodium channel epithelial 1 subunit delta, transcript variant X1
sodium channel epithelial 1 subunit delta, transcript variant X2
amiloride-sensitive sodium channel subunit delta
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 74 samples with support for all annotated introns
C1q and TNF related 12, transcript variant X1
C1q and TNF related 12, transcript variant X2
beta-1,3-galactosyltransferase 6, transcript variant X1
beta-1,3-galactosyltransferase 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments
tumor necrosis factor receptor superfamily member 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
tumor necrosis factor receptor superfamily member 18
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA lysine (anticodon UUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
rho guanine nucleotide exchange factor 7-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
rho guanine nucleotide exchange factor 7-like isoform X2
rho guanine nucleotide exchange factor 7-like, transcript variant X1
pleckstrin homology domain-containing family N member 1-like isoform X1
chromosome 24 C1orf159 homolog, transcript variant X1
chromosome 24 C1orf159 homolog, transcript variant X3
chromosome 24 C1orf159 homolog, transcript variant X2
uncharacterized protein C1orf159 homolog
ring finger protein 223, transcript variant X1
ring finger protein 223, transcript variant X2
tyrosine-protein phosphatase non-receptor type 11-like, transcript variant X1
tyrosine-protein phosphatase non-receptor type 11-like, transcript variant X2
tyrosine-protein phosphatase non-receptor type 11-like isoform X1
tyrosine-protein phosphatase non-receptor type 11-like isoform X2
tyrosine-protein phosphatase non-receptor type 11-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
tyrosine-protein phosphatase non-receptor type 11-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
PPARGC1 and ESRR induced regulator, muscle 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
PPARGC1 and ESRR induced regulator, muscle 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
PPARGC1 and ESRR induced regulator, muscle 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
PPARGC1 and ESRR induced regulator, muscle 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
PPARGC1 and ESRR induced regulator, muscle 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
PGC-1 and ERR-induced regulator in muscle protein 1 isoform X1
PGC-1 and ERR-induced regulator in muscle protein 1 isoform X2
PGC-1 and ERR-induced regulator in muscle protein 1 isoform X3
PGC-1 and ERR-induced regulator in muscle protein 1 isoform X4
pleckstrin homology domain containing N1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
pleckstrin homology domain-containing family N member 1
kelch like family member 17, transcript variant X1
kelch like family member 17, transcript variant X2
NOC2 like nucleolar associated transcriptional repressor
sterile alpha motif domain containing 11, transcript variant X13
sterile alpha motif domain containing 11, transcript variant X12
sterile alpha motif domain containing 11, transcript variant X10
sterile alpha motif domain containing 11, transcript variant X4
sterile alpha motif domain containing 11, transcript variant X3
sterile alpha motif domain containing 11, transcript variant X6
sterile alpha motif domain containing 11, transcript variant X2
sterile alpha motif domain containing 11, transcript variant X1
sterile alpha motif domain containing 11, transcript variant X5
sterile alpha motif domain containing 11, transcript variant X15
sterile alpha motif domain containing 11, transcript variant X7
sterile alpha motif domain containing 11, transcript variant X14
sterile alpha motif domain containing 11, transcript variant X18
sterile alpha motif domain containing 11, transcript variant X9
sterile alpha motif domain containing 11, transcript variant X17
sterile alpha motif domain containing 11, transcript variant X11
sterile alpha motif domain containing 11, transcript variant X16
sterile alpha motif domain containing 11, transcript variant X8
sterile alpha motif domain containing 11, transcript variant X19
sterile alpha motif domain-containing protein 11 isoform X6
sterile alpha motif domain-containing protein 11 isoform X2
sterile alpha motif domain-containing protein 11 isoform X4
sterile alpha motif domain-containing protein 11 isoform X3
sterile alpha motif domain-containing protein 11 isoform X5
sterile alpha motif domain-containing protein 11 isoform X1
sterile alpha motif domain-containing protein 11 isoform X8
sterile alpha motif domain-containing protein 11 isoform X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
arginine-glutamic acid dipeptide repeats, transcript variant X2
arginine-glutamic acid dipeptide repeats, transcript variant X4
arginine-glutamic acid dipeptide repeats, transcript variant X8
arginine-glutamic acid dipeptide repeats, transcript variant X7
arginine-glutamic acid dipeptide repeats, transcript variant X3
arginine-glutamic acid dipeptide repeats, transcript variant X1
arginine-glutamic acid dipeptide repeats, transcript variant X6
arginine-glutamic acid dipeptide repeats, transcript variant X5
arginine-glutamic acid dipeptide repeats, transcript variant X10
arginine-glutamic acid dipeptide repeats, transcript variant X9
arginine-glutamic acid dipeptide repeats protein isoform X3
arginine-glutamic acid dipeptide repeats protein isoform X6
arginine-glutamic acid dipeptide repeats protein isoform X5
arginine-glutamic acid dipeptide repeats protein isoform X2
arginine-glutamic acid dipeptide repeats protein isoform X1
arginine-glutamic acid dipeptide repeats protein isoform X7
arginine-glutamic acid dipeptide repeats protein isoform X8
arginine-glutamic acid dipeptide repeats protein isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
carbonic anhydrase 6, transcript variant X2
carbonic anhydrase 6, transcript variant X1
solute carrier family 2 member 5, transcript variant X2
solute carrier family 2 member 5, transcript variant X1
solute carrier family 2 member 5, transcript variant X3
solute carrier family 2, facilitated glucose transporter member 5 isoform X1
solute carrier family 2, facilitated glucose transporter member 5 isoform X2
G protein-coupled receptor 157, transcript variant X1
G protein-coupled receptor 157, transcript variant X2
hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
GDH/6PGL endoplasmic bifunctional protein
splA/ryanodine receptor domain and SOCS box containing 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
splA/ryanodine receptor domain and SOCS box containing 1, transcript variant X5
splA/ryanodine receptor domain and SOCS box containing 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
splA/ryanodine receptor domain and SOCS box containing 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
splA/ryanodine receptor domain and SOCS box containing 1, transcript variant X2
SPRY domain-containing SOCS box protein 1 isoform X2
SPRY domain-containing SOCS box protein 1 isoform X1
solute carrier family 25 member 33, transcript variant X1
solute carrier family 25 member 33 isoform X1
solute carrier family 25 member 33, transcript variant X2
solute carrier family 25 member 33 isoform X2
transmembrane protein 201, transcript variant X4
transmembrane protein 201, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
transmembrane protein 201, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 60 samples with support for all annotated introns
transmembrane protein 201, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
transmembrane protein 201, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 61 samples with support for all annotated introns
phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
beta-catenin-interacting protein 1, transcript variant X1
beta-catenin-interacting protein 1, transcript variant X2
beta-catenin-interacting protein 1, transcript variant X7
beta-catenin-interacting protein 1, transcript variant X5
beta-catenin-interacting protein 1, transcript variant X4
beta-catenin-interacting protein 1, transcript variant X6
beta-catenin-interacting protein 1, transcript variant X3
beta-catenin-interacting protein 1, transcript variant X9
beta-catenin-interacting protein 1, transcript variant X8
beta-catenin-interacting protein 1, transcript variant X10
beta-catenin-interacting protein 1 isoform X9
leucine zipper and CTNNBIP1 domain containing, transcript variant X2
leucine zipper and CTNNBIP1 domain containing, transcript variant X1
nicotinamide nucleotide adenylyltransferase 1, transcript variant X6
nicotinamide nucleotide adenylyltransferase 1, transcript variant X2
nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1 isoform X2
nicotinamide nucleotide adenylyltransferase 1, transcript variant X1
nicotinamide nucleotide adenylyltransferase 1, transcript variant X4
nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1 isoform X1
nicotinamide nucleotide adenylyltransferase 1, transcript variant X3
nicotinamide nucleotide adenylyltransferase 1, transcript variant X5
nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1 isoform X3
ubiquitination factor E4B, transcript variant X1
ubiquitination factor E4B, transcript variant X2
ubiquitination factor E4B, transcript variant X3
ubiquitination factor E4B, transcript variant X4
ubiquitination factor E4B, transcript variant X5
ubiquitination factor E4B, transcript variant X6
ubiquitin conjugation factor E4 B isoform X1
ubiquitin conjugation factor E4 B isoform X2
ubiquitin conjugation factor E4 B isoform X3
ubiquitin conjugation factor E4 B isoform X4
ubiquitin conjugation factor E4 B isoform X5
ubiquitin conjugation factor E4 B isoform X6
uncharacterized LOC101930913, transcript variant X6
uncharacterized LOC101930913, transcript variant X4
uncharacterized LOC101930913, transcript variant X2
uncharacterized LOC101930913, transcript variant X5
uncharacterized LOC101930913, transcript variant X1
uncharacterized LOC101930913, transcript variant X3
kinesin family member 1B, transcript variant X10
kinesin family member 1B, transcript variant X1
kinesin family member 1B, transcript variant X7
kinesin family member 1B, transcript variant X4
kinesin family member 1B, transcript variant X3
kinesin family member 1B, transcript variant X5
kinesin family member 1B, transcript variant X2
kinesin family member 1B, transcript variant X6
kinesin family member 1B, transcript variant X8
kinesin family member 1B, transcript variant X9
6-phosphogluconate dehydrogenase, decarboxylating
DNA fragmentation factor subunit alpha, transcript variant X2
DNA fragmentation factor subunit alpha, transcript variant X1
DNA fragmentation factor subunit alpha isoform X2
DNA fragmentation factor subunit alpha isoform X1
castor zinc finger 1, transcript variant X3
castor zinc finger 1, transcript variant X6
castor zinc finger 1, transcript variant X4
castor zinc finger 1, transcript variant X5
castor zinc finger 1, transcript variant X9
castor zinc finger 1, transcript variant X7
castor zinc finger 1, transcript variant X8
castor zinc finger 1, transcript variant X1
castor zinc finger 1, transcript variant X10
castor zinc finger 1, transcript variant X2
zinc finger protein castor homolog 1 isoform X3
zinc finger protein castor homolog 1 isoform X4
zinc finger protein castor homolog 1 isoform X9
zinc finger protein castor homolog 1 isoform X8
zinc finger protein castor homolog 1 isoform X6
zinc finger protein castor homolog 1 isoform X7
zinc finger protein castor homolog 1 isoform X1
zinc finger protein castor homolog 1 isoform X2
zinc finger protein castor homolog 1 isoform X5
TAR DNA binding protein, transcript variant X1
TAR DNA binding protein, transcript variant X2
MBL associated serine protease 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 207 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
mannan-binding lectin serine protease 2 isoform X1
MBL associated serine protease 2, transcript variant X2
mannan-binding lectin serine protease 2 isoform X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: spermidine synthase
mechanistic target of rapamycin kinase, transcript variant X8
mechanistic target of rapamycin kinase, transcript variant X7
mechanistic target of rapamycin kinase, transcript variant X5
mechanistic target of rapamycin kinase, transcript variant X4
mechanistic target of rapamycin kinase, transcript variant X3
mechanistic target of rapamycin kinase, transcript variant X2
mechanistic target of rapamycin kinase, transcript variant X6
mechanistic target of rapamycin kinase, transcript variant X1
serine/threonine-protein kinase mTOR isoform X8
serine/threonine-protein kinase mTOR isoform X7
serine/threonine-protein kinase mTOR isoform X5
serine/threonine-protein kinase mTOR isoform X4
serine/threonine-protein kinase mTOR isoform X3
serine/threonine-protein kinase mTOR isoform X2
serine/threonine-protein kinase mTOR isoform X6
serine/threonine-protein kinase mTOR isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
UbiA prenyltransferase domain containing 1, transcript variant X3
UbiA prenyltransferase domain containing 1, transcript variant X2
UbiA prenyltransferase domain containing 1, transcript variant X1
ubiA prenyltransferase domain-containing protein 1
dispatched RND transporter family member 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
dispatched RND transporter family member 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
dispatched RND transporter family member 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
F-box only protein 6, transcript variant X2
F-box only protein 6, transcript variant X3
F-box only protein 6, transcript variant X1
mitotic arrest deficient 2 like 2, transcript variant X2
mitotic arrest deficient 2 like 2, transcript variant X1
mitotic spindle assembly checkpoint protein MAD2B isoform X2
mitotic spindle assembly checkpoint protein MAD2B isoform X1
dorsal inhibitory axon guidance protein, transcript variant X2
dorsal inhibitory axon guidance protein, transcript variant X1
dorsal inhibitory axon guidance protein, transcript variant X3
angiotensin II receptor associated protein, transcript variant X2
angiotensin II receptor associated protein, transcript variant X1
type-1 angiotensin II receptor-associated protein isoform X2
type-1 angiotensin II receptor-associated protein isoform X1
chromosome 24 C1orf167 homolog, transcript variant X4
chromosome 24 C1orf167 homolog, transcript variant X5
chromosome 24 C1orf167 homolog, transcript variant X1
chromosome 24 C1orf167 homolog, transcript variant X6
chromosome 24 C1orf167 homolog, transcript variant X2
chromosome 24 C1orf167 homolog, transcript variant X7
chromosome 24 C1orf167 homolog, transcript variant X3
chromosome 24 C1orf167 homolog, transcript variant X9
uncharacterized protein C1orf167 homolog isoform X1
uncharacterized protein C1orf167 homolog isoform X2
uncharacterized protein C1orf167 homolog isoform X3
uncharacterized protein C1orf167 homolog isoform X4
chromosome 24 C1orf167 homolog, transcript variant X8
uncharacterized protein C1orf167 homolog isoform X5
uncharacterized protein C1orf167 homolog isoform X6
methylenetetrahydrofolate reductase, transcript variant X1
methylenetetrahydrofolate reductase, transcript variant X2
methylenetetrahydrofolate reductase, transcript variant X3
methylenetetrahydrofolate reductase, transcript variant X4
methylenetetrahydrofolate reductase isoform X1
methylenetetrahydrofolate reductase isoform X2
chloride voltage-gated channel 6, transcript variant X3
chloride voltage-gated channel 6, transcript variant X1
chloride voltage-gated channel 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00426
uncharacterized protein KIAA2013 homolog
procollagen-lysine,2-oxoglutarate 5-dioxygenase 1
migration and invasion inhibitory protein
LOW QUALITY PROTEIN: migration and invasion-inhibitory protein
tumor necrosis factor receptor superfamily member 8
TNF receptor superfamily member 1B, transcript variant X2
TNF receptor superfamily member 1B, transcript variant X1
TNF receptor superfamily member 1B, transcript variant X3
tumor necrosis factor receptor superfamily member 1B isoform X1
tumor necrosis factor receptor superfamily member 1B isoform X2
tumor necrosis factor receptor superfamily member 1B isoform X3
vacuolar protein sorting 13 homolog D, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 44 samples with support for all annotated introns
vacuolar protein sorting 13 homolog D, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
vacuolar protein sorting 13 homolog D, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 47 samples with support for all annotated introns
vacuolar protein sorting 13 homolog D, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 46 samples with support for all annotated introns
vacuolar protein sorting 13 homolog D, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
vacuolar protein sorting 13 homolog D, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 47 samples with support for all annotated introns
vacuolar protein sorting 13 homolog D, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 50 samples with support for all annotated introns
vacuolar protein sorting 13 homolog D, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
vacuolar protein sorting 13 homolog D, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
vacuolar protein sorting-associated protein 13D isoform X1
vacuolar protein sorting-associated protein 13D isoform X3
vacuolar protein sorting-associated protein 13D isoform X5
vacuolar protein sorting-associated protein 13D isoform X2
vacuolar protein sorting-associated protein 13D isoform X4
vacuolar protein sorting-associated protein 13D isoform X6
dehydrogenase/reductase 3, transcript variant X3
dehydrogenase/reductase 3, transcript variant X2
dehydrogenase/reductase 3, transcript variant X1
short-chain dehydrogenase/reductase 3 isoform X3
short-chain dehydrogenase/reductase 3 isoform X1
short-chain dehydrogenase/reductase 3 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 74% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 42% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 24% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein C1orf158 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 44 samples with support for all annotated introns
leucine-rich repeat-containing protein 38
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
LOW QUALITY PROTEIN: PR domain zinc finger protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
kazrin, periplakin interacting protein, transcript variant X2
kazrin, periplakin interacting protein, transcript variant X1
uncharacterized LOC101938187, transcript variant X2
uncharacterized LOC101938187, transcript variant X1
kazrin, periplakin interacting protein, transcript variant X5
kazrin, periplakin interacting protein, transcript variant X6
kazrin, periplakin interacting protein, transcript variant X7
kazrin, periplakin interacting protein, transcript variant X3
kazrin, periplakin interacting protein, transcript variant X4
forkhead associated phosphopeptide binding domain 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
forkhead associated phosphopeptide binding domain 1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
forkhead associated phosphopeptide binding domain 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
forkhead associated phosphopeptide binding domain 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
forkhead associated phosphopeptide binding domain 1, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
forkhead associated phosphopeptide binding domain 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
forkhead associated phosphopeptide binding domain 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
forkhead associated phosphopeptide binding domain 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
forkhead associated phosphopeptide binding domain 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
forkhead associated phosphopeptide binding domain 1, transcript variant X9
forkhead associated phosphopeptide binding domain 1, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
forkhead-associated domain-containing protein 1 isoform X1
forkhead-associated domain-containing protein 1 isoform X3
forkhead-associated domain-containing protein 1 isoform X4
forkhead-associated domain-containing protein 1 isoform X2
forkhead-associated domain-containing protein 1 isoform X8
forkhead-associated domain-containing protein 1 isoform X5
forkhead-associated domain-containing protein 1 isoform X6
forkhead-associated domain-containing protein 1 isoform X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 47 Proteins, and 75% coverage of the annotated genomic feature by RNAseq alignments
chymotrypsin-like elastase family member 2A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 49 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
DnaJ heat shock protein family (Hsp40) member C16, transcript variant X5
DnaJ heat shock protein family (Hsp40) member C16, transcript variant X1
DnaJ heat shock protein family (Hsp40) member C16, transcript variant X2
DnaJ heat shock protein family (Hsp40) member C16, transcript variant X3
DnaJ heat shock protein family (Hsp40) member C16, transcript variant X4
dnaJ homolog subfamily C member 16 isoform X1
dnaJ homolog subfamily C member 16 isoform X2
dnaJ homolog subfamily C member 16 isoform X3
dnaJ homolog subfamily C member 16 isoform X4
dnaJ homolog subfamily C member 16 isoform X5
LOW QUALITY PROTEIN: agmatinase, mitochondrial
serine/threonine-protein kinase PINK1, mitochondrial
cytidine deaminase, transcript variant X4
cytidine deaminase, transcript variant X2
cytidine deaminase, transcript variant X3
cytidine deaminase, transcript variant X1
family with sequence similarity 43 member B
mitochondrial E3 ubiquitin protein ligase 1, transcript variant X3
mitochondrial E3 ubiquitin protein ligase 1, transcript variant X1
mitochondrial E3 ubiquitin protein ligase 1, transcript variant X5
mitochondrial E3 ubiquitin protein ligase 1, transcript variant X2
mitochondrial E3 ubiquitin protein ligase 1, transcript variant X4
mitochondrial ubiquitin ligase activator of NFKB 1
calcium/calmodulin dependent protein kinase II inhibitor 1
calcium/calmodulin-dependent protein kinase II inhibitor 1
von Willebrand factor A domain containing 5B1
LOW QUALITY PROTEIN: von Willebrand factor A domain-containing protein 5B1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
group IIF secretory phospholipase A2-like
basic phospholipase A2 sphenotoxin subunit B-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 56% coverage of the annotated genomic feature by RNAseq alignments
ring finger protein 186, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
ring finger protein 186, transcript variant X1
ring finger protein 186, transcript variant X2
E3 ubiquitin-protein ligase RNF186 isoform X1
ring finger protein 186, transcript variant X4
E3 ubiquitin-protein ligase RNF186 isoform X2
transmembrane and coiled-coil domains 4, transcript variant X2
transmembrane and coiled-coil domains 4, transcript variant X4
transmembrane and coiled-coil domains 4, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
transmembrane and coiled-coil domains 4, transcript variant X3
transmembrane and coiled-coil domains 4, transcript variant X1
transmembrane and coiled-coil domain-containing protein 4 isoform X1
transmembrane and coiled-coil domain-containing protein 4 isoform X3
transmembrane and coiled-coil domain-containing protein 4 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
neuroblastoma suppressor of tumorigenicity 1, transcript variant X1
neuroblastoma suppressor of tumorigenicity 1, transcript variant X2
neuroblastoma suppressor of tumorigenicity 1 isoform X1
neuroblastoma suppressor of tumorigenicity 1 isoform X2
mitochondrial contact site and cristae organizing system subunit 10
capping actin protein of muscle Z-line subunit beta, transcript variant X3
capping actin protein of muscle Z-line subunit beta, transcript variant X1
capping actin protein of muscle Z-line subunit beta, transcript variant X2
F-actin-capping protein subunit beta isoform X2
F-actin-capping protein subunit beta isoform X1
F-actin-capping protein subunit beta isoform X3
lysosomal amino acid transporter 1 homolog
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: aflatoxin B1 aldehyde reductase member 2
MRT4 homolog, ribosome maturation factor
ER membrane protein complex subunit 1, transcript variant X1
ER membrane protein complex subunit 1, transcript variant X2
ER membrane protein complex subunit 1 isoform X1
ER membrane protein complex subunit 1 isoform X2
ER membrane protein complex subunit 1, transcript variant X3
ER membrane protein complex subunit 1 isoform X3
ubiquitin protein ligase E3 component n-recognin 4, transcript variant X1
ubiquitin protein ligase E3 component n-recognin 4, transcript variant X3
ubiquitin protein ligase E3 component n-recognin 4, transcript variant X2
ubiquitin protein ligase E3 component n-recognin 4, transcript variant X4
E3 ubiquitin-protein ligase UBR4 isoform X1
E3 ubiquitin-protein ligase UBR4 isoform X3
E3 ubiquitin-protein ligase UBR4 isoform X2
E3 ubiquitin-protein ligase UBR4 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
immunoglobin superfamily member 21, transcript variant X3
immunoglobin superfamily member 21, transcript variant X1
immunoglobin superfamily member 21, transcript variant X2
immunoglobulin superfamily member 21 isoform X1
immunoglobulin superfamily member 21 isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 638 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Rho guanine nucleotide exchange factor 10 like, transcript variant X1
Rho guanine nucleotide exchange factor 10 like, transcript variant X2
Rho guanine nucleotide exchange factor 10 like, transcript variant X4
Rho guanine nucleotide exchange factor 10 like, transcript variant X3
Rho guanine nucleotide exchange factor 10 like, transcript variant X5
Rho guanine nucleotide exchange factor 10 like, transcript variant X6
Rho guanine nucleotide exchange factor 10 like, transcript variant X7
Rho guanine nucleotide exchange factor 10 like, transcript variant X8
rho guanine nucleotide exchange factor 10-like protein isoform X4
rho guanine nucleotide exchange factor 10-like protein isoform X3
rho guanine nucleotide exchange factor 10-like protein isoform X2
rho guanine nucleotide exchange factor 10-like protein isoform X1
rho guanine nucleotide exchange factor 10-like protein isoform X5
rho guanine nucleotide exchange factor 10-like protein isoform X7
rho guanine nucleotide exchange factor 10-like protein isoform X6
LOW QUALITY PROTEIN: protein-arginine deiminase type-3
ciliary rootlet coiled-coil, rootletin, transcript variant X6
ciliary rootlet coiled-coil, rootletin, transcript variant X5
ciliary rootlet coiled-coil, rootletin, transcript variant X7
ciliary rootlet coiled-coil, rootletin, transcript variant X1
ciliary rootlet coiled-coil, rootletin, transcript variant X3
ciliary rootlet coiled-coil, rootletin, transcript variant X2
ciliary rootlet coiled-coil, rootletin, transcript variant X4
LOW QUALITY PROTEIN: adaptin ear-binding coat-associated protein 2
SUZ RNA binding domain containing 1, transcript variant X4
SUZ RNA binding domain containing 1, transcript variant X2
SUZ RNA binding domain containing 1, transcript variant X3
SUZ RNA binding domain containing 1, transcript variant X1
SUZ RNA binding domain containing 1, transcript variant X5
SUZ domain-containing protein 1 isoform X4
SUZ domain-containing protein 1 isoform X2
SUZ domain-containing protein 1 isoform X3
SUZ domain-containing protein 1 isoform X1
SUZ domain-containing protein 1 isoform X5
Rho guanine nucleotide exchange factor 19
rho guanine nucleotide exchange factor 19-like
family with sequence similarity 131 member C
LOW QUALITY PROTEIN: chloride channel protein ClC-Kb
heat shock protein family B (small) member 7
uncharacterized LOC122173976, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC122173976, transcript variant X1
zinc finger and BTB domain containing 17, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 56 samples with support for all annotated introns
zinc finger and BTB domain-containing protein 17 isoform X1
zinc finger and BTB domain containing 17, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
zinc finger and BTB domain-containing protein 17 isoform X2
zinc finger and BTB domain containing 17, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
zinc finger and BTB domain-containing protein 17 isoform X3
LOW QUALITY PROTEIN: msx2-interacting protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
transmembrane protein 82, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
transmembrane protein 82, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
pleckstrin homology and RUN domain containing M2
pleckstrin homology domain-containing family M member 2
complement C1q B chain, transcript variant X1
complement C1q B chain, transcript variant X2